Navigation Links
Dog Study Raises Prospect of Biological Pacemaker for Humans
Date:2/27/2013

By Randy Dotinga
HealthDay Reporter

WEDNESDAY, Feb. 27 (HealthDay News) -- If your heart doesn't beat correctly, you can get an electronic pacemaker and live happily ever after -- or at least until it wears out and you need another one.

Now, the results of an animal study add to existing evidence that people may one day have an alternative to living out their days with an electronic device implanted in their chests: gene therapy.

The research, reported recently in the Journal of the American College of Cardiology, is preliminary and was performed only in dogs with heart trouble. It's too early to know if a similar strategy would work in humans, how long it would last and if the costs and side effects would be tolerable.

"It's not something I would expect to be working in the short term," said Matteo Vatta, director of the cardiovascular genetics section at Indiana University, who co-wrote a commentary about the findings. Still, he said, "it's not impossible to think about a biological pacemaker."

So what's wrong with traditional pacemakers, which have been around for decades and now often come with defibrillators to shock the heart into a steady rhythm if necessary? They can cause side effects, Vatta said, and require surgery that can spawn complications.

In the new study, researchers induced heart problems in 24 dogs, implanted electronic pacemakers in them and then injected a gene-carrying virus into their hearts. The researchers found that the hearts of some of the dogs were able to beat properly without needing the pacemakers to kick into gear.

Dr. Steven Pogwizd, a professor of cardiac arrhythmia research at the University of Alabama at Birmingham, said the study's findings show promise.

"Ultimately, the goal of a pacemaker is to replicate the normal electrical activation of the heart as closely as possible, and this approach may have the potential to do so," Pogwizd said.

Vatta said the study is promising because the gene-therapy approach allows the heart to beat at more normal rates than electronic pacemakers do.

Also, he said, it shows that targeting the heart's electronic system, instead of the heart muscle, is possible. This may help show researchers where to target the gene-therapy treatment in the future, he said.

But there are challenges, Vatta added. For one, a gene-based pacemaker would have to perform better than existing electronic pacemakers, which have "a long track record and a well-established safety and durability profile," he said. Also, electronic pacemakers can control the upper and lower chambers of the heart; gene-based pacemakers cannot do that, he said.

"It is also unclear how the sophisticated programmability that modern electronic pacemakers currently have will be achieved by biological pacemakers," Vatta said.

For now, Pogwizd said, more research is needed to examine issues like effectiveness, safety and durability. Still, the gene approach offers the prospect of a treatment that could replace electronic pacemakers or be used as part of a hybrid treatment with them, he said.

More information

For more about pacemakers, try the U.S. National Library of Medicine.

SOURCES: Matteo Vatta, Ph.D., director, cardiovascular genetics section, Molecular Genetics Diagnostic Laboratory, and associate professor, clinical medical & molecular genetics, Indiana University, Indianapolis; Steven Pogwizd, M.D., professor, cardiac arrhythmia research, University of Alabama at Birmingham; Feb. 6, 2013, Journal of the American College of Cardiology, online


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Dog Study Raises Prospect of Biological Pacemaker for Humans
(Date:3/22/2017)... Angeles, CA (PRWEB) , ... March 22, 2017 ... ... information community, announces the publication of the first issue of its companion print ... educate the public about cosmetic surgery thanks to information provided by board-certified doctors ...
(Date:3/22/2017)... San Francisco, CA (PRWEB) , ... March 22, ... ... headquartered in the California Bay Area providing insurance assistance, financial planning, and related ... conjunction with Endangered Species International to promote awareness of threatened species and wild ...
(Date:3/22/2017)... ... March 22, 2017 , ... The American Society ... authorization (PA) form for prescribers to improve patients’ access to the revolutionary therapy ... published as part of the article entitled “PCSK9 Inhibitor Access Barriers: Issues ...
(Date:3/22/2017)... ... 2017 , ... Soriant recognizes that identifying savings opportunities can ... facilities across the country are always forced to focus on costs and budgets. ... country, an efficient and quick way to estimate savings potential within specific support ...
(Date:3/22/2017)... ... March 22, 2017 , ... In recognition ... print media enterprise focused on cancer patients, cancer centers and advocacy groups, and ... 12-part educational video series, “No Ifs, Ands, or Butts,” that focuses on Colorectal ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , March 22, 2017 Under the ... pharmaceutical packaging market size increased year by year ... 2017 to 2021, the market size will maintain ... expected to outnumber RMB140 billion in 2021, thanks ... rapid development of biological agents and supporting policies. ...
(Date:3/22/2017)... PRINCETON, N.J. , March 22, 2017 ... systems averted 77,342 cases of patient harm and saved ... thanks to their participation in a national quality improvement ... of progress under Partnership for Patients-New Jersey, part of ... and Human Services. HHS selected the New Jersey Hospital ...
(Date:3/22/2017)... 2017 Research and Markets has announced ... Market & Clinical Pipeline Insight 2022" drug pipelines to ... ... Pipeline Insight 2022 report gives comprehensive insight on clinical and ... check point inhibitors as main streamline drugs in the immunotherapy ...
Breaking Medicine Technology: